Annual banned-substance review Research articles Contents continued overleaf 8(1) (2016) ISSN

Size: px
Start display at page:

Download "Annual banned-substance review Research articles Contents continued overleaf 8(1) (2016) ISSN"

Transcription

1 1 Volume 8 Number 1, January 2016 Annual banned-substance review Detection assays for drugs and methods of sports doping published between 2014 and 2015 are critically reviewed and evaluated in context with the Prohibited List 2015 as established by the World Anti-Doping Agency. Annual banned-substance review: analytical approaches in human sports drug testing 7 29 M. Thevis, T. Kuuranne, K. Walpurgis, H. Geyer and W. Schänzer Research articles The development of the first fully automated method for the determination of opioids in dried blood spots is described. Selective, sensitive, accurate, and reproducible quantitation of five representative opioids at sub therapeutic, therapeutic, and toxic levels can be achieved within 5 min. Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on line SPE LC MS/MS R. Verplaetse and J. Henion Comprehensive UHPLC HR TOF MS based confirmation level screening was employed to determine the accurate drug abuse patterns of drug users with different attendance for drug treatment. Those subjects regularly attending treatment mainly abused medicinal buprenorphine and benzodiazepines. Conversely, the conventional illicit drugs amphetamine and cannabis were more frequent among the subjects irregularly attending treatment, together with a higher rate of new psychoactive substances and polydrug abuse. Treatment of drug abusers thus could be valuable in reducing polydrug abuse. Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC HR TOF MS M. Sundström, A. Pelander, K. Simojoki and I. Ojanperä 8(1) (2016) ISSN

2 Reviews β Glucan is a valuable molecule molecule for the human and animal health system. The yeast cell wall, particularly of baker's and brewer's yeast Saccharomyces cerevisiae, is an important source of β D glucans. For yeast β glucan, many extraction methods have been proposed. Yeast cells can be exploited for β glucan production. Brewery and winery spent yeast biomass can comprise an alternative source for β glucan production. An evaluation study of different methods for the production of β D glucan from yeast biomass V. Varelas, M. Liouni, A. C. Calokerinos and E. T. Nerantzis Literature review suggests cannabinoid analysis as essential requirement to estimate the time of last cannabis intake supporting a temporal relationship between marijuana smoking and CVD. Any scientific interference about a causal link between cannabis use and CVD remains plausible but not completely established. Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature D. Marchetti, A. Spagnolo, V. De Matteis, L. Filograna and N. De Giovanni During the three year period of we have found the new psychoactive substances (NPS) in 112 cases. The drugs detected were: 3 MMC, α PVP, MDPBP, UR 144, ethcathinone, mephedrone, MDPV, 4 MEC, buphedrone, 2 DPMP, methylone and 2C B. In single cases, 2 MMC, 2C P, eutylone, 25I NBOMe, mcpp, ephedrone, MPA and 5 APB were found. The prevalence of new psychoactive substances in biological material a threeyear review of casework in Poland P. Adamowicz, J. Gieroń, D. Gil, W. Lechowicz, A. Skulska and B. Tokarczyk 2

3 3 Pharmaceutical applications of NIR CI in each unit operation during the manufacturing processes, from the Western solid dosage forms to the Chinese materia medica preparations, are reviewed. PAT: From Western solid dosage forms to Chinese materia medica preparations using NIR CI L. Zhou, M. Xu, Z. Wu, X. Shi and Y. Qiao Research articles A method is developed and validated for simultaneous screening and quantification of 24 analytes of forensic relevance in vitreous humour, blood and plasma using LC MS/MS. The method is advantageous over other methods due to its simplified sample preparation protocol and less sample requirement. The method is well applied for screening of drugs in post mortem samples collected at autopsy. Development and validation of an ESI LC MS/ MS method for simultaneous identification and quantification of 24 analytes of forensic relevance in vitreous humour, whole blood and plasma B. Arora, T. Velpandian, R. Saxena, S. Lalwani, T. D. Dogra and S. Ghose 2 Methoxydiphenidine (2 MXP) has recently appeared as a research chemical and is suspected to show dissociative properties in humans. This study presents the identification of 2 MXP in various products obtained from test purchases from UK based vendors. Further verification was obtained by organic synthesis of three positional MXP isomers. Furthermore, the implementation of matrix assisted inlet ionization Orbitrap mass spectrometry confirmed the ability to detect the protonated molecule of 2 MXP directly from the tablet surface following addition of 3 nitrobenzonitrile as the matrix. Test purchase, synthesis, and characterization of 2 methoxydiphenidine (MXP) and differentiation from its meta and parasubstituted isomers G. McLaughlin, N. Morris, P. V. Kavanagh, J. D. Power, J. O'Brien, B. Talbot, S. P. Elliott, J. Wallach, K. Hoang, H. Morris and S. D. Brandt

4 The influence of several factors in the excretion of testosterone metabolites (Δ 1 AED, Δ 6 AED, Δ 6 T and Δ 15 AD) conjugated with cysteine is evaluated. These factors are divided into sample preservation (microbial degradation and freeze/thaw cycles), endogenous factors (gender, ultradian and circadian rhythms, pregnancy and UGT2B17 polymorphism), and exogenous factors (alcohol and 5α reductase inhibitors). The results show the stability of the urinary cysteinyl steroids under the influence of many factors, proving their potential as adequate parameters to be included in screening procedures applied in doping control. Factors affecting urinary excretion of testosterone metabolites conjugated with cysteine A. Fabregat, J. Marcos, J. Segura, R. Ventura and O. J. Pozo Short communications QTc shortening has been suggested as a method of screening for anabolic steriod abuse. This study evaluates the accuracy of such a test in a group of a long term steriod users. Prolonged androgenic anabolic steroid (AAS) induced QT interval shortening: a suitable screening tool? N. Sculthorpe, L. Taylor and F. M. Grace A new SPE HPLC MS method was developed to measure progestins and applied for the analysis of freshwater samples from Lake Balaton. HPLC MS/MS analysis of steroid hormones in environmental water samples P. Avar, G. Maasz, P. Takács, S. Lovas, Z. Zrinyi, R. Svigruha, A. Takátsy, L. G. Tóth and Z. Pirger 4

5 Handling cannabis plant material leads to a relevant and persistent contamination of hair with Δ 9 tetrahydrocannabinolic acid A (THCA A) and Δ 9 tetrahydrocannabinol (THC). Concentrations and pattern of distribution along the hair shaft are not distinguishable from typical results in hair samples of known cannabis users. In the light of the results of this study, any use of THC cut off concentrations in hair to evaluate consumption habits or frequency is strongly discouraged. Hair analysis for Δ9 tetrahydrocannabinolic acid A (THCA A) and Δ9 tetrahydrocannabinol (THC) after handling cannabis plant material B. Moosmann, N. Roth and V. Auwärter Correspondence case report Smoking habits of italian athletes undergoing anti doping control R. Pacifici, S. Pichini, I. Palmi, X. de la Torre and F. Botrè and the Anti-doping Commission at the Ministry of Health Application note The use of presumptive color tests for new psychoactive substances E. Cuypers, A.-J. Bonneure and J. Tytgat Research article Following intra articular administration to exercised Thoroughbred horses isoflupredone was detected for up to 36 and 48 h in plasma and urine, respectively. Furthermore, as isoflupredone was detected in synovial fluid for up to 14 days post administration, urine and blood concentrations do not appear to be good indicators of drug concentrations at the effector site and by and by extrapolation may not be useful in determining the duration of pharmacologic effect. Disposition of isoflupredone acetate in plasma, urine and synovial fluid following intra articular administration to exercised Thoroughbred horses H. K. Knych, L. M. Harrison, A. White and D. S. McKemie 5

WADA Technical Document TD2017MRPL

WADA Technical Document TD2017MRPL MINIMUM REQUIRED PERFORMANCE LEVELS FOR DETECTION AND IDENTIFICATION OF NON-THRESHOLD SUBSTANCES In order to ensure that all WADA-accredited Laboratories can report the presence of Prohibited Substances,

More information

Fiona Coope (BSc) Forensics Director

Fiona Coope (BSc) Forensics Director Fiona Coope (BSc) Forensics Director Who We Are ESG is the UK s leading provider of testing, inspection and compliance services, with comprehensive solutions in Infrastructure, the Built Environment and

More information

DART MSI of drugs of abuse in hair

DART MSI of drugs of abuse in hair DART MSI of drugs of abuse in hair Wilco Duvivier, Teris van Beek, Michel Nielen October 5, 2017 Forensic hair evidence Forensically interesting: Many compounds accumulate in hair Prolonged detectability

More information

The 2018 Prohibited List will be effective 1 January As usual there are some changes.

The 2018 Prohibited List will be effective 1 January As usual there are some changes. TO: PSA ATHLETES and MEMBER NATIONS WADA PROHIBITED LIST 2018 The 2018 Prohibited List will be effective 1 January 2018. As usual there are some changes. Below is a synopsis of the major modifications.

More information

SCREENING OF NEW PSYCHOACTIVE SUBSTANCES IN URINE SAMPLES BY HIGH RESOLUTION MASS SPECTROMETRY

SCREENING OF NEW PSYCHOACTIVE SUBSTANCES IN URINE SAMPLES BY HIGH RESOLUTION MASS SPECTROMETRY SCREENING OF NEW PSYCHOACTIVE SUBSTANCES IN URINE BY HIGH RESOLUTION MASS SPECTROMETRY Noelia Salgueiro-González, Sara Castiglioni, Emma Gracia-Lor, Nikolaos I. Rousis, Lubertus Bijlsma, Alberto Celma,

More information

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Application Note Forensics, Workplace Drug Testing Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Authors Fred Feyerherm and Anthony Macherone Agilent Technologies, Inc.

More information

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology

Application. Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS. Introduction. Authors. Abstract. Forensic Toxicology Detection of Cannabinoids in Oral Fluid Using Inert Source GC/MS Application Forensic Toxicology Authors Christine Moore, Sumandeep Rana, and Cynthia Coulter Immunalysis Corporation 829 Towne Center Drive

More information

Detection of synthetic cannabinoids in hair

Detection of synthetic cannabinoids in hair Detection of synthetic cannabinoids in hair Alberto Salomone Lisbon, 28 th May 2015 Rise of NPS Arise of critical situations Acute intoxication Workplace testing Driving re-licensing Anti-doping analyses

More information

Analytic Techniques Utilisedfor Drug Checking

Analytic Techniques Utilisedfor Drug Checking Analytic Techniques Utilisedfor Drug Checking Challenges and Current Developments Anton Luf Head of checkit! Laboratory Clinical Institute for Laboratory Medicine Medical University of Vienna checkit!

More information

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer application Note Liquid Chromatography/ Mass Spectrometry Authors Sharanya Reddy Blas Cerda PerkinElmer, Inc. Shelton, CT USA Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate

More information

Enantiomeric Separation of Clenbuterol as Analytical Strategy to Distinguish Abuse from Meat Contamination

Enantiomeric Separation of Clenbuterol as Analytical Strategy to Distinguish Abuse from Meat Contamination Enantiomeric Separation of enbuterol as Analytical Strategy to Distinguish Abuse from Meat Contamination CHINADA-WADA, October 18-19 th 2017, Saskia S. Sterk Outline Introduction (very short) Hypothesis

More information

Objectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse

Objectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse New drugs of abuse: synthetic cannabinoids, stimulants, and more Robert G. Hendrickson, MD Professor, Emergency Medicine, OHSU Program Director, Medical Toxicology Fellowship Associate Medical Director,

More information

First experiences with GC-C-IRMS to detect natural hormone abuse in cattle. Dr. Eva de Rijke RIKILT Wageningen UR

First experiences with GC-C-IRMS to detect natural hormone abuse in cattle. Dr. Eva de Rijke RIKILT Wageningen UR First experiences with GC-C-IRMS to detect natural hormone abuse in cattle Dr. Eva de Rijke 26-4-2013 RIKILT Wageningen UR Outline Introduction GC-C-IRMS for hormone analysis Performance characteristics

More information

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection Application Note Cannabis Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection Authors Mike Adams, Annette Roth, Sue D

More information

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications

More information

Novel psychoactive substances in postmortem toxicology. Pirkko Kriikku, PhD Forensic Toxicologist

Novel psychoactive substances in postmortem toxicology. Pirkko Kriikku, PhD Forensic Toxicologist Novel psychoactive substances in postmortem toxicology Pirkko Kriikku, PhD Forensic Toxicologist Postmortem toxicology in Finland Population: 5.5 million Deaths: ~51 000 per year Medico-legal cause-of-death

More information

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement

More information

2009 Prohibited List

2009 Prohibited List September 20 th, 2008 2009 Prohibited List Summary of Major Modifications and Clarifications INTRODUCTORY PARAGRAPH Article 4.2.2 of the 2009 Code states: For purposes of the application of Article 10

More information

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts

SmartNotes. Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts DIAGNOSTICS Synthetic Cannabinoids SmartNotes Why test for synthetic cannabinoids? Synthetic Cannabinoids Facts Largest group of New Psychoactive Substances (NPS) on the market Mind-altering chemicals

More information

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl Designer Fentanyls Drugs that kill and how to detect them Cyclopropylfentanyl Science for a safer world The in vitro metabolism of cyclopropylfentanyl Simon Hudson & Charlotte Cutler, Sport and Specialised

More information

T R A I N I N G G U I D E

T R A I N I N G G U I D E TRAINING GUIDE InstaCube Oral Fluid Drug Test For Forensic Use Only Powered By: Contents 3 The information in this presentation is a general overview on performing and interpreting the InstaCube Oral Fluid

More information

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF

The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF The Challenges of Analytical Method Validation for Hallucinogens and Designer Stimulants in Biological Samples Using LC-TOF Barry K Logan, Ph.D., NMS Labs National Director, Forensic Services Goals The

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Newmarket Road Fordham Ely Cambridgeshire CB7 5WW Contact: Rachel Hawkins Tel: +44 (0)1638 720500 Fax: +44 (0)1638 724200 E-Mail: rachel.hawkins@lgcgroup.com Website: www.lgcgroup.com Testing performed

More information

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED: Payment Policy Drug Testing EFFECTIVE DATE: 05 23 2013 POLICY LAST UPDATED: 06 05 2018 OVERVIEW This policy documents the criteria and documentation requirements for immunoassay (IA) testing (also called

More information

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns Jacquelyn Runco, Andrew Aubin, and Catharine Layton Waters Corporation, Milford, MA, USA APPLICATION BENEFITS

More information

Conventional and emerging drugs of abuse: the current situation

Conventional and emerging drugs of abuse: the current situation Conventional and emerging drugs of abuse: the current situation NEW PSYCHOACTIVE SUBSTANCES -THE HIGHS AND LOWS Maritim Hotel, Munich, 12-13 November 2015 Michael Uhl Director of Chemistry Unit Bavarian

More information

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 9 Infinity II/63B LC/TOF system Application Brief Authors Mike Adams, Karen Kaikaris, and A. Roth CWC Labs Joan Stevens, Sue D

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2207/15 6

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: January 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.2 T0 Effective Date: January 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES

More information

NIH Public Access Author Manuscript Clin Chem. Author manuscript; available in PMC 2013 July 21.

NIH Public Access Author Manuscript Clin Chem. Author manuscript; available in PMC 2013 July 21. NIH Public Access Author Manuscript Published in final edited form as: Clin Chem. 2011 June ; 57(6): 805 810. doi:10.1373/clinchem.2010.152124. Oral Fluid Testing: Promises and Pitfalls Marilyn A. Huestis

More information

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Detection of Drugs-of-Abuse by Tandem Mass Spectrometry. Dr Tim Laurens MSc.Chem(Pretoria), Ph.D. Chem (Pretoria), MSc.Toxicology (Surrey,UK) FRSChem, MFSSoc Email: laurensj@lancet.co.za / tim.laurens@up.ac.za

More information

Urine Testing and Abuse Patterns of Drugs and New Psychoactive Substances Application of Comprehensive Time-of-Flight Mass Spectrometry

Urine Testing and Abuse Patterns of Drugs and New Psychoactive Substances Application of Comprehensive Time-of-Flight Mass Spectrometry dissertationes scholae doctoralis ad sanitatem investigandam universitatis helsinkiensis 49/2017 MIRA SUNDSTRÖM Urine Testing and Abuse Patterns of Drugs and New Psychoactive Substances Application of

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1

Rapid Hydrolysis of Benzodiazepines in Urine. Alicia Zook 1 and Crystal Xander B.S. 2. Cedar Crest College, Allentown, PA 1 Rapid Hydrolysis of Benzodiazepines in Urine Alicia Zook 1 and Crystal Xander B.S. 2 Cedar Crest College, Allentown, PA 1 Health Network Laboratories, Allentown, PA 2 Abstract: Benzodiazepines are sedative/hypnotic

More information

Metabolomics: quantifying the phenotype

Metabolomics: quantifying the phenotype Metabolomics: quantifying the phenotype Metabolomics Promises Quantitative Phenotyping What can happen GENOME What appears to be happening Bioinformatics TRANSCRIPTOME What makes it happen PROTEOME Systems

More information

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs

Flakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs Flakka : The Truth Behind the Latest Designer Drug Media Storm Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs Flakka Flakka Headlines What is Flakka? Flakka = Spanish slang for thin, pretty

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Substances under Surveillance

Substances under Surveillance Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Rapid and Robust Detection of THC and Its Metabolites in Blood

Rapid and Robust Detection of THC and Its Metabolites in Blood Rapid and Robust Detection of THC and Its Metabolites in Blood Application Note Forensics/Doping Control Author Stephan Baumann Agilent Technologies, Inc. Santa Clara CA 95051 USA Abstract A robust method

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: March 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.3 T0 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES OF

More information

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None

DRUG TESTING POLICY. Policy Number: ADMINISTRATIVE T0 Effective Date: October 1, Related Policies None DRUG TESTING POLICY UnitedHealthcare Oxford Reimbursement Policy Policy Number: ADMINISTRATIVE 259.1 T0 Effective Date: October 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 APPLICABLE LINES

More information

SECTION 1 LEARNING OBJECTIVES:

SECTION 1 LEARNING OBJECTIVES: CHAPTER 5 DRUGS SECTION 1 LEARNING OBJECTIVES: 1. Define psychological and physical dependence. 2. Name and classify the commonly abused drugs. 3. Describe the tendency to develop psychological and physical

More information

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides

More information

WADA Technical Document TD2017CG/LH

WADA Technical Document TD2017CG/LH REPORTING & MANAGEMENT of URINARY HUMAN CHORIONIC GONADOTROPHIN (hcg) and LUTEINIZING HORMONE (LH) FINDINGS IN MALE ATHLETES The purpose of this Technical Document is to ensure a harmonized approach in

More information

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections *

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections * Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections * Michael L. Smith 1, Allan J. Barnes 2, and Marilyn A. Huestis 2,

More information

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation Valérie Thibert, Bénédicte Duretz Thermo Fisher Scientific, Courtaboeuf,

More information

MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS

MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS MARIHUANA AND DRIVING: WHAT IS THE SIGNIFICANCE OF CANNABINOID CONCENTRATIONS? * * A. McBay, M.D. ; and A. P. Mason SYNOPSIS It has been inferred that significant driving impairment can result from marihuana

More information

Recent changes and new trends observed regarding drug use

Recent changes and new trends observed regarding drug use Recent changes and new trends observed regarding drug use Recent changes and new trends in drug use General Population 15 to 64 years old Prev.% 2012 Prev. %2014 Var. Illegal 9.34 13.39 43.3% Marijuanas

More information

Altering Perception and Dirty Deeds. Forensic Science Part #D

Altering Perception and Dirty Deeds. Forensic Science Part #D Bell-Ringer Forensic Science What are the classifications of Heroin/Cocaine? What is the primary system these types of drugs effect? What is the typical cause of death with overdose> Altering Perception

More information

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee Reimbursement Policy CMS 1500 Drug Testing Policy Policy Number 2017R6005A Annual Approval Date 05/10/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY

More information

Drug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products.

Drug Testing Policy. Approved By 05/10/2017. Application This reimbursement policy applies to UnitedHealthcare Community Plan Medicaid products. Policy Number 2017R6005B Annual Approval Date Drug Testing Policy 05/10/2017 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY You are responsible for

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

When Anti-Doping reveals pathology an Australian experience

When Anti-Doping reveals pathology an Australian experience When Anti-Doping reveals pathology an Australian experience WADA TUE Symposium Dr Susan White ASDMAC Chair. Member WADA TUE-EG, Member FINA DCRB hcg normal physiological production hcg is a glycoprotein

More information

POLICY NUMBER: POL 153

POLICY NUMBER: POL 153 Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines

More information

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS Julie Cichelli, PhD Agilent Technologies Application Engineer April 29, 2014 Agenda A method for the rapid analysis

More information

New patterns of drug use in Hungary

New patterns of drug use in Hungary New patterns of drug use in Hungary Gergely Horváth Hungarian National Focal Point PDU Annual Expert Meeting 2012 Lisbon, 25-26 September 2012 First glance From 2009 on decrease in heroin availability,

More information

National Drug Intelligence Bureau. Environmental Science and Research

National Drug Intelligence Bureau. Environmental Science and Research National Drug Intelligence Bureau & Environmental Science and Research Wastewater Analysis for Illicit Drug Use A Joint Presentation Chemical Analysis of Wastewater Samples to Monitor the Use of Illicit

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire

More information

Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS

Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS UCT Part Numbers CSXCE106 Clean Screen XCEL I 130mg / 6mL SPE Cartridge SPHACE5001-5 Select

More information

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS TECHNICAL NOTE 21883 Fast and easy separation of 23 drugs of abuse including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS Authors Kean Woodmansey 1, Jon Bardsley 1 and Stacy

More information

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry Application Note Food Safety Authors Chenhao Zhai Agilent

More information

Possibility of Use a Saliva for Determination Ethanol and Opiates

Possibility of Use a Saliva for Determination Ethanol and Opiates Possibility of Use a Saliva for Determination Ethanol and Opiates Wojciech Piekoszewski 1,2, Wojciech Gubała 1, Ewa Janowska 1, Janusz Pach 3, Dariusz Zuba 1 1 Institute of Forensic Research, Westerplatte

More information

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry

2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry Dr. Sanjeeva Srivastava 1. Fundamental of Mass Spectrometry Role of MS and basic concepts 2. Ionization Sources 3. Mass Analyzers 4. Tandem Mass Spectrometry 2 1 MS basic concepts Mass spectrometry - technique

More information

Drug Profiles of Apprehended Drivers in Victoria

Drug Profiles of Apprehended Drivers in Victoria Drug Profiles of Apprehended Drivers in Victoria J Gerostamoulos, P McCaffrey, O H. Drummer and M Odell*. Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, 57-83

More information

Drug Testing Policy. Approved By 06/14/2017

Drug Testing Policy. Approved By 06/14/2017 Drug Testing Policy Policy Number Annual Approval Date 06/14/2017 Approved By Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare Medicare Advantage

More information

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS UCT Part Numbers SSHLD063 Styre Screen HLD 60 mg, 6 ml column SPHPHO6001-5 Select ph Buffer Pouches 100 mm Phosphate

More information

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly Utilization of the urine drug screen: The good, the bad, and the ugly Jennifer A. Lowry, MD Chief, Section of Medical Toxicology Children s Mercy Hospital Kansas City, MO Learning Objectives Describe the

More information

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2201/15 27

More information

Solving practical problems. Maria Kuhtinskaja

Solving practical problems. Maria Kuhtinskaja Solving practical problems Maria Kuhtinskaja What does a mass spectrometer do? It measures mass better than any other technique. It can give information about chemical structures. What are mass measurements

More information

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015

The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015 The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015 New Psychoactive Substances Any substance, natural or synthetic which can produce stimulation or

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2106/14

More information

Detection and characterization of urinary metabolites of boldione. Part I: phase I

Detection and characterization of urinary metabolites of boldione. Part I: phase I Detection and characterization of urinary metabolites of boldione. Part I: phase I metabolites excreted free and conjugated with glucuronic acid or sulphate and released after alkaline treatment of the

More information

Forensic Toxicology Findings in DRDs. Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science

Forensic Toxicology Findings in DRDs. Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science Forensic Toxicology Findings in DRDs Dr Hazel Torrance Manager of the Forensic Toxicology Service Forensic Medicine and Science Forensic Toxicology at the University of Glasgow Dept of Forensic Medicine

More information

SPICE Prevention Issues Measures in Switzerland in the fight against new drugs such as SPICE and bath salts

SPICE Prevention Issues Measures in Switzerland in the fight against new drugs such as SPICE and bath salts SPICE Prevention Issues 2012 Measures in Switzerland in the fight against new drugs such as SPICE and bath salts Werner Bernhard, Lars Ambach, Wolfgang Weinmann Institute of Forensic Medicine, University

More information

Metabolism of new synthetic cannabinoids and detection of metabolites in urine samples

Metabolism of new synthetic cannabinoids and detection of metabolites in urine samples Spice II Plus project conference June 05 th 2014, Lisbon, Portugal Metabolism of new synthetic cannabinoids and detection of s in urine samples Florian Franz, Melanie Hutter, Verena Angerer, Volker Auwärter

More information

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry Palm Springs, California February 21-25 Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry Junfang Zhao, Chandra Sharat, Parinda A. Mehta,

More information

Several possible toxicological and genetic tools for the extension of the detection window after GHB intake

Several possible toxicological and genetic tools for the extension of the detection window after GHB intake Toxichem Krimtech 2017;84(3):184 Several possible toxicological and genetic tools for the extension of the detection window after GHB intake Lena-Maria Mehling 1,*, Thomas Piper 2, Susanne Lott 1, Xin

More information

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of

More information

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF APPLICATIO OTE Liquid Chromatography/ Mass Spectrometry Authors: Avinash Dalmia Joanne Mather PerkinElmer, Inc. Shelton, CT Workflow for Screening and Quantification of the SAMHSA (IDA) Panel in Urine

More information

2017 Drug Screen Tests

2017 Drug Screen Tests 2017 Drug Screen Tests The ABCs of Applying the CMS 2017 HCPCS Codes Written by: Karen D. Chappell, EJD, MBA, CIRCC, CPMA, CPC-I, CHC Terminology Immunoassay Qualitative Therapeutic Quantitative GC/MS

More information

Challenges of New Emerging Designer Drugs

Challenges of New Emerging Designer Drugs EDITORIAL Challenges of New Emerging Designer Drugs There is an emerging use of what are popularly called designer drugs (Bauman et al., 2014). In the media, they are often called motedop or synthetic

More information

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee

Drug Testing Policy. Reimbursement Policy CMS Approved By. Policy Number. Annual Approval Date. Reimbursement Policy Oversight Committee Reimbursement Policy CMS 1500 Drug Testing Policy Policy Number 2018R6005A Annual Approval Date 07/11/2018 Approved By Reimbursement Policy Oversight Committee IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY

More information

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS SCIEX QTRAP 4500 LC-MS/MS System and Spark Holland PICO Adrian M. Taylor 1, Peter Ringeling 2, Martin Sibum 2, Stefan Sturm

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

A review of the collision induced dissociation fragmentation and the metabolism of synthetic cathinone derivatives

A review of the collision induced dissociation fragmentation and the metabolism of synthetic cathinone derivatives A review of the collision induced dissociation fragmentation and the metabolism of synthetic cathinone derivatives Nichola Cunningham A thesis submitted in fulfilment of the requirements for the degree

More information

Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection

Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection A. S. Christophersen¹, A. M. Hausken¹ and S. Skurtveit¹ ² ¹National Institute of Forensic Toxicology, P.O. Box 495

More information

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS Application Note Forensic Toxicology Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca

More information

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016 LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES Gilles Frache Materials Characterization Day October 14 th 2016 1 MOLECULAR ANALYSES Which focus? LOCALIZATION of molecules by Mass Spectrometry

More information

NARCOTIC NOTES FLIPBOOK BY: PER:

NARCOTIC NOTES FLIPBOOK BY: PER: NARCOTIC NOTES FLIPBOOK BY: PER: 1 https://www.youtube. com/watch?v=lolb21bii-a 2 Laws, Collection, & Preservation Narcotic Drugs = natural or synthetic substance that produces bodily (physiological) or

More information

Drug Threats in the United States: 2019 Update

Drug Threats in the United States: 2019 Update Drug Threats in the United States: 209 Update J I L L M. H E A D S P E C I A L T E S T I N G A N D R E S E A R C H L A B O R AT O R Y D R U G E N F O R C E M E N T A D M I N I S T R AT I O N Objectives.

More information

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Serum Using UHPLC-TOF

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Serum Using UHPLC-TOF APPLICATIO OTE Liquid Chromatography/ Mass Spectrometry Authors: Avinash Dalmia Bonnie Marmor PerkinElmer, Inc. Shelton, CT Workflow for Screening and Quantification of the SAMHSA (IDA) Panel in Serum

More information

Lab Tests Made Simple

Lab Tests Made Simple Body Fluids Commonly Used for Testing Steroid Hormones Blood Serum (venipuncture) Plasma (venipuncture) Capillary Blood (finger/heel stick) Urine Saliva Limitations of Hormone Testing in Different Body

More information

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system Xiang He 1, Adrian Taylor 2 and Alexandre Wang 1 1 SCIEX, Redwood City, USA. 2 SCIEX, Concord,

More information

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Jennifer P. Pascali, PhD. dtolabs, Resana (TV) Jennifer P. Pascali, PhD dtolabs, Resana (TV) Agilent Technologies Users Meeting, 20 May 2014 The project dtolabs dtolabs is an analytical research centre founded by two leading companies in the production

More information